These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2832192)

  • 81. Inhibition by calcium channel blockers of the glycogenolytic effect of glucagon in perfused rat liver.
    Kimura S; Matsumoto T; Tada R; Ogata E; Abe K
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):559-66. PubMed ID: 6280434
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stimulation of glycogenolysis and vasoconstriction by adenosine and adenosine analogues in the perfused rat liver.
    Buxton DB; Fisher RA; Robertson SM; Olson MS
    Biochem J; 1987 Nov; 248(1):35-41. PubMed ID: 2829826
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
    Buxton DB; Fisher RA; Hanahan DJ; Olson MS
    J Biol Chem; 1986 Jan; 261(2):644-9. PubMed ID: 3001074
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatocyte heterogeneity in response to extracellular adenosine.
    Morimoto Y; Wettstein M; Häussinger D
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):573-81. PubMed ID: 8393665
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activation of glycogenolysis by the reduction in the extracellular calcium concentration in verapamil-perfused rat liver.
    Koide Y; Kimura S; Tada R; Kugai N; Yamashita K
    Biochem Pharmacol; 1983 Feb; 32(3):517-22. PubMed ID: 6303349
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Potentiation of the glycogenolytic and haemodynamic actions of adenosine in the perfused rat liver by verapamil.
    Buxton DB
    Eur J Pharmacol; 1988 Jan; 146(1):121-7. PubMed ID: 2832192
    [TBL] [Abstract][Full Text] [Related]  

  • 87.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 88.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.